Collaboration To Maximise Strategic Strengths

BMI View: Drugmakers who have moved into emerging markets more slowly than many of their competitors will look to mergers, acquisitions and joint ventures (JVs) with established distributors to increase market share. This may take the form of acquiring local drugmakers or companies can form JVs with other manufactures that do not have overlapping product portfolios, such as consumer healthcare companies involved in the retail

To read the full article, please choose one of the following options: